a
a
Weather:
No weather information available
HomeHealthQuarterly report Q2/2025: Strong development in Sweden and increased international activity: Enzymatica AB

Quarterly report Q2/2025: Strong development in Sweden and increased international activity: Enzymatica AB

LUND, Sweden, July 17, 2025 /PRNewswire/ — Second quarter Net sales reached SEK 8.3 (6.4) million. The operating result totaled SEK -14.9 (-13.5) million. Earnings per share, basic and diluted, were SEK -0.06 (-0.08). Cash flow from operating activities totaled SEK -21.3 (-19.0) million….

No comments

Sorry, the comment form is closed at this time.

Translate »